Journal article
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials
Authors
Papi A; Greening NJ; Bhatt SP; Roche N; Celli B; Wedzicha JA; Agustí À; Tal-Singer R; Han MK; Janssens W
Journal
The Lancet, , ,
Publisher
Elsevier BV
Publication Date
May 18, 2026
DOI
10.1016/s0140-6736(26)00637-9
ISSN
0140-6736